| Item Type | Name |
|
Concept
|
Research Personnel
|
|
Concept
|
Research Support as Topic
|
|
Concept
|
Research
|
|
Concept
|
Peer Review, Research
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Research Design
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Comparative Effectiveness Research
|
|
Concept
|
Ethics Committees, Research
|
|
Concept
|
Qualitative Research
|
|
Concept
|
Health Services Research
|
|
Concept
|
Research Subjects
|
|
Concept
|
Research Report
|
|
Academic Article
|
Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
|
|
Academic Article
|
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
|
|
Academic Article
|
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.
|
|
Academic Article
|
Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.
|
|
Academic Article
|
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer.
|
|
Academic Article
|
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
|
|
Academic Article
|
Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.
|
|
Academic Article
|
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
|
|
Academic Article
|
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
|
|
Academic Article
|
Oral fluoropyrimidine treatment of colorectal cancer.
|
|
Academic Article
|
Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs.
|
|
Academic Article
|
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
|
|
Academic Article
|
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine.
|
|
Academic Article
|
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
|
|
Academic Article
|
The role of cooperative groups in cancer clinical trials.
|
|
Academic Article
|
3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.
|
|
Academic Article
|
American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
|
|
Academic Article
|
The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics).
|
|
Academic Article
|
Introduction: contributions of the cooperative groups.
|
|
Academic Article
|
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.
|
|
Academic Article
|
Are targeted therapies really targeted?
|
|
Academic Article
|
The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
|
|
Academic Article
|
Translating the cancer genome into clinically useful tools and strategies.
|
|
Academic Article
|
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
|
|
Academic Article
|
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
|
|
Academic Article
|
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
|
|
Academic Article
|
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
|
Academic Article
|
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
|
|
Academic Article
|
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.
|
|
Academic Article
|
Clinical trials in the era of personalized oncology.
|
|
Academic Article
|
Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
|
|
Academic Article
|
Using patient-initiated study participation in the development of evidence for personalized cancer therapy.
|
|
Academic Article
|
Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.
|
|
Academic Article
|
The next phase of chemoprevention research.
|
|
Academic Article
|
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
|
|
Academic Article
|
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
|
|
Academic Article
|
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.
|
|
Academic Article
|
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.
|
|
Academic Article
|
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.
|
|
Academic Article
|
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
|
|
Academic Article
|
Target practice: oncology drug development in the era of genomic medicine.
|
|
Academic Article
|
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
|
|
Academic Article
|
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.
|
|
Academic Article
|
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.
|
|
Academic Article
|
Randomized controlled trials and comparative effectiveness research.
|
|
Academic Article
|
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
|
|
Academic Article
|
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
|
|
Academic Article
|
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
|
|
Academic Article
|
Precision cancer medicine: the future is now, only better.
|
|
Academic Article
|
Breaking a vicious cycle.
|
|
Academic Article
|
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
|
|
Academic Article
|
Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.
|
|
Academic Article
|
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis.
|
|
Academic Article
|
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
|
|
Academic Article
|
Drivers of change in cancer care.
|
|
Academic Article
|
Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
|
|
Academic Article
|
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.
|
|
Academic Article
|
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
|
|
Academic Article
|
Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
|
|
Academic Article
|
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
|
|
Academic Article
|
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
|
|
Academic Article
|
Reply to F.E. Vera-Badillo et al.
|
|
Academic Article
|
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement.
|
|
Academic Article
|
Modernizing Eligibility Criteria for Molecularly Driven Trials.
|
|
Academic Article
|
Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.
|
|
Academic Article
|
Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise.
|
|
Academic Article
|
The promise of Immuno-oncology: implications for defining the value of cancer treatment.
|
|
Academic Article
|
Challenges and approaches to implementing master/basket trials in oncology.
|
|
Academic Article
|
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.
|
|
Academic Article
|
Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology.
|
|
Academic Article
|
Discrepancies in Financial Self-Disclosures and Open Payments Reporting Among Authors of Clinical Oncology Research Studies.
|
|
Academic Article
|
The International Collaboration for Cancer Classification and Research.
|
|
Academic Article
|
Progress in Cancer Research, Prevention, and Care.
|
|
Academic Article
|
Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
|
|
Academic Article
|
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
|
|
Academic Article
|
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.
|
|
Academic Article
|
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
|
|
Academic Article
|
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
|
|
Academic Article
|
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations.
|
|
Academic Article
|
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
|
|
Academic Article
|
What can heart failure trialists learn from oncology trialists?
|
|
Academic Article
|
The Porto European Cancer Research Summit 2021.
|
|
Academic Article
|
Patient Experiences, Trust, and Preferences for Health Data Sharing.
|
|
Academic Article
|
Beyond the COVID-19 Pandemic: Sustaining and Improving Equitable Cancer Care and Research.
|
|
Concept
|
Patient Outcome Assessment
|
|
Grant
|
Cancer and Leukemia Group B
|
|
Grant
|
Cancer and Leukemia Group B Human Specimen Repositories
|
|
Grant
|
CALGB STUDIES OF BREAST CANCER IN THE ELDERLY
|
|
Grant
|
Cancer and Leukemia Group B CCOP Research Base
|
|
Academic Article
|
The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial.
|